Vineet Laboratories Approves Audited FY26 Standalone Results, Reports Net Profit of ₹72.51 Lakh
Vineet Laboratories Limited's Board approved audited standalone financial results for FY26. The company reported a net profit of ₹72.51 lakh for Q4 FY26, a substantial turnaround from a loss in the prior year. For the full year FY26, net profit stood at ₹111.08 lakh, also a significant improvement. The company confirmed an unmodified audit opinion.
The announcement details the financial performance for the quarter and year-end, which is material information for investors. The turnaround from losses to profits is a significant development, but the absolute profit figures are relatively modest.
The company reported a profitable quarter and financial year after a period of losses, indicating a positive turnaround. The unmodified audit opinion further strengthens the positive sentiment.
Vineet Laboratories Limited announced the outcome of its Board Meeting held on August 25, 2026. The Board approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended March 31, 2026, along with the Audited Standalone Financial Statement and Audit Report. The company confirmed that the Statutory Auditors, NSVR & Associates LLP, have issued an audit report with an unmodified opinion.
The financial results for the quarter ended March 31, 2026, show a net profit of ₹72.51 lakh, a significant improvement from a loss of ₹1,052.51 lakh in the corresponding quarter of the previous year. For the full financial year ended March 31, 2026, the company reported a net profit of ₹111.08 lakh, compared to a loss of ₹2,019.19 lakh in the previous year.
The company also provided details regarding its borrowings for the financial year ended March 31, 2025, and March 31, 2026. Outstanding long-term borrowings at the start of FY25 were ₹39.09 crore, decreasing to ₹35.29 crore by the end of FY26. There were no incremental borrowings or issuances of debt securities during the year. Vineet Laboratories confirmed it is not classified as a Large Corporate as per SEBI regulations.
The Board Meeting commenced at 3:00 PM and concluded at 6:30 PM on August 25, 2026.
What to do with a filing like this
Vineet Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vineet Laboratories Limited. Read the original for the full detail.